Monday, November 5, 2018
Friday, October 12, 2018
We extend a blithesome welcome to our World Congress on Pain Medicine and Research Conference Which is going to be held on February 20-21, 2019 at Singapore.
Pain Medicine conference will give a perfect platform for sharing and developing innovative ideas on the latest developments and future perspectives in the field of Medical and Palliative care for the treatment of various disorders. Attending the Pain Medicine 2019 is an investment in your career growth. It’s the best way to express your passion towards the Pain research and update your skills and enhance your knowledge.
Pain Medicine congress 2019 participants include Professors, Researchers, Physicians, Business Delegates, Scientists, students all over the world. The goal of the Pain Medicine congress 2019 is to provide you with a rare opportunity to build on what you already know in the research and development of new therapies and techniques and accelerate efforts to enhance health and well-being.
Pain Medicine congress 2019 is supported with related journals and their editorial board members which provide a chance of meeting them, along with experts in Pain medicine research, Palliative care and Pharmacological sciences.In order to accelerate the research in the field of Medical . Conference Series organizes different conferences worldwide.
Summary of Pain medicine congress 2019:
Pain is a signal in your nervous system that something may be wrong. It is an unpleasant feeling, such as a prick, tingle, sting, burn, or ache. Pain may be sharp or dull. It may come and go, or it may be constant
Treatment depends on the cause and type of pain. There are drug treatments, including pain relievers. There are also non-drug treatments, such as acupuncture, physical therapy, and sometimes surgery.
Pain relievers are medicines that reduce or relieve headaches, sore muscles, arthritis, or other aches and pains. There are many different pain medicines, and each one has advantages and risks. Some types of pain respond better to certain medicines than others. Each person may also have a slightly different response to a pain reliever.
Market analysis around the globe:
The scope of the report includes a detailed study of global and regional markets for pain management therapeutics with the reasons given for variations in the growth of the industry in certain regions.
The pain management therapeutics market is expected to exceed more than US$ 83 Billion by 2024; Growing at a CAGR of more than 3.5% in the given forecast period
Market analysis around Singapore:
Singapore ranks among the highest in the world for body and head pain, according the 2017 GSK Global Pain Index which surveyed 19,000 adults across 32 countries. About 85 per cent of 500 Singaporeans surveyed reported having experienced head and body pain, with four in 10 suffering body pain every week. It currently sees more than 6,000 patients each year, a number which is expected to rise exponentially with the rapidly ageing population.
The scope of this study encompasses psychiatric drugs in pharmaceutical markets. Technological issues include the latest trends and developments. The emerging market for enzyme inhibitors includes countries like India, China, Japan, Korea, Taiwan, Canada, Africa, Australia, New Zealand, etc.
Scope and importance:
Pain is one of the most common reasons clients seek medical attention, and is a symptom that is encountered by every health care provider. Health care professionals must be knowledgeable regarding effective and compassionate pain relief, while clients and their families should be assured such relief will be provided. Communication and collaboration between members of the healthcare team, the client and the family are essential in achieving adequate pain management. Ideally, the client directs the plan of care and the pain level to be achieved.
Chronic pain affects approximately 100 million in the US, making it one of the most common reasons for patients to seek medical care. Moreover, there are inadequate numbers of pain management specialists to help generalist providers manage these patients. Partly in response to the problem of under-treatment of pain, over the past decade there has been a four-fold increase in opioid prescribing. During the same time period there was a four-fold increase in unintentional opioid overdose deaths and a five-fold increase in substance abuse treatment admissions for prescription opioid addiction. Providers who prescribe ER/LA opioid analgesics to treat chronic pain are in a key position to balance the benefits and risks of chronic opioid therapy (COT). However, providers struggle with the need to assist their patients with adequate management of chronic pain while confronting the risks associated with opioid prescribing.
Why in Singapore:
Palliative care in Singapore has grown over the past few years and has benefited recently by public interest in end-of-life care. There are challenges that include the recruitment, education and retention of health care professionals interested in this field. Our clinical management of cancer pain needs to be reviewed and audited, and further research in this field in our part of the world will help inform our practice.
- Pain Medicine
- Acute and Chronic Pain
- New Frontiers in Neuropathic Pain
- Headache and Migraine
- Pain Management Specialist
- Orofacial Pain
- Neuropathic Pain & Neuro Orthopaedics
- Arthritis & Inflammation
- Cancer Pain Management
- Pediatric Pain Management
- Acute Pancreatitis
- Anesthesia as Pain Treatment
- NSAIDs and Analgesics
- All accepted abstracts will be published in respective Supporting International Journals.
- Abstracts will be provided with Digital Object Identifier by Cross Ref.
See more at:- https://painmedicine.pharmaceuticalconferences.com/